Eisai and Biogen are one step away from deploying a more convenient version of their jointly developed Alzheimer’s treatment Leqembi (lecanemab-irmb) after the US Food and Drug Administration (FDA) ...

Around 20% of Allegheny County’s population is 65 and older, according to recent studies, placing among the highest ...

To date, Leqembi has been approved in the US, Japan, China, South Korea, Hong Kong, Israel, UAE, GB, Mexico, and Macau, and ...

The findings highlight the need for public-health strategies aimed at mitigating dementia risk and promoting healthy aging across diverse populations, researchers said. “I think ...

In a simulated trial, the Florey Dementia Index achieved mean absolute errors of 1.57 and 0.70 years for predicting mild cognitive impairment and Alzheimer's disease onset, respectively ...

The Tennessee Lady Volunteers are set to host its annual “We Back Pat” game at Food City Center on Thursday against ...

Topline results from a phase 2b/3 clinical trial of blarcamesine for individuals with early-stage Alzheimer’s disease showed ...

Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues ...

Researchers at New York’s Mount Sinai Hospital have developed a cutting-edge AI-powered algorithm which could aid in the ...

Am I a doomed man? When I was 25, I survived a battle with testicular cancer. The good news is that 45 years later, after two ...

AJ from the WPLR’s “Chaz and AJ Show” revealed on the air last Monday that he recently has battled a variety of health issues ...